EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Molecular Docking Studies of 5-Trifluoromethoxy-2-Indolinones as Cholinesterase Dual Inhibitors

Özge Soylu-Eter iD, Nurten Özsoy iD, Nilgün Karalı iD

Future Medicinal Chemistry · 2024

DOI: 10.4155/fmc-2023-0281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Özge Soylu-Eter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, 34116, Istanbul, Turkey. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Alzheimer Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Alzheimer's disease, butyrylcholinesterase (BuChE) activity gradually increases, while acetylcholinesterase (AChE) activity decreases or remains unchanged. Dual inhibitors have important roles in regulation of synaptic acetylcholine levels and progression of Alzheimer's disease.

Methods

1-(Thiomorpholin-4-ylmethyl)/benzyl-5-trifluoromethoxy-2-indolinones (6-7) were synthesized. AChE and BuChE inhibitory effects were investigated with Ellman's method. Molecular docking studies were performed for analyzing the possible binding interactions at active sites.

Results

Compound 6g was the strongest inhibitor against both AChE (Ki = 0.35 μM) and BuChE (Ki = 0.53 μM). It showed higher inhibitory effects than both donepezil and galantamine. Moreover, compound 7m had a higher inhibitory effect than galantamine and the effect was comparable to that of donepezil against both AChE (Ki = 0.69 μM) and BuChE (Ki = 0.95 μM).

Conclusion

The benzyl substitution compared with 1-(thiomorpholin-4-ylmethyl) group significantly increased both AChE and BuChE inhibitory effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAlzheimer DiseaseHumansDonepezilGalantamineMolecular Docking SimulationButyrylcholinesteraseAcetylcholinesteraseOxindoles

Stichwörter der Autor:innen

5-trifluoromethoxy-2-indolinonesacetylcholinesterase inhibitorsbutyrylcholinesterase inhibitorshydrazinecarbothioamidemolecular docking

Substanzen

Cholinesterase InhibitorsDonepezilGalantamine2-oxindoleButyrylcholinesteraseAcetylcholinesteraseOxindoles

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, 34116, Istanbul, Turkey.
  • Department of Pharmaceutical Chemistry, Institute of Health Sciences, Istanbul University, 34126, Istanbul, Turkey.
  • Department of Biochemistry, Faculty of Pharmacy, Istanbul University, 34116, Istanbul, Turkey.

ORCID-Profile: Özge Soylu-Eter, Nurten Özsoy, Nilgün Karalı

Zitieren

APA

Soylu-Eter, Ö., Özsoy, N., & Karalı, N. (2024). Synthesis and Molecular Docking Studies of 5-Trifluoromethoxy-2-Indolinones as Cholinesterase Dual Inhibitors. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0281

Vancouver

Soylu-Eter Ö, Özsoy N, Karalı N. Synthesis and Molecular Docking Studies of 5-Trifluoromethoxy-2-Indolinones as Cholinesterase Dual Inhibitors. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2023-0281

BibTeX
@article{SoyluEter2024,
  author = {Soylu-Eter, Özge and Özsoy, Nurten and Karalı, Nilgün},
  title = {Synthesis and Molecular Docking Studies of 5-Trifluoromethoxy-2-Indolinones as Cholinesterase Dual Inhibitors},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.4155/fmc-2023-0281}
}
Kostenlos starten →